Austrian recommendations for the management of essential thrombocythemia.

Veronika Buxhofer-Ausch; Sonja Heibl; Thamer Sliwa; Christine Beham-Schmid; Dominik Wolf; Klaus Geissler; Maria Theresa Krauth; Peter Krippl; Andreas Petzer; Albert Wölfler; Thomas Melchardt; Heinz Gisslinger

doi:10.1007/s00508-020-01761-3

Austrian recommendations for the management of essential thrombocythemia.

Veronika Buxhofer-Ausch, Sonja Heibl, Thamer Sliwa, Christine Beham-Schmid, Dominik Wolf, Klaus Geissler, Maria Theresa Krauth, Peter Krippl, Andreas Petzer, Albert Wölfler, Thomas Melchardt (Co-author), Heinz Gisslinger

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article (Journal) › peer-review

3 Citations (Web of Science)

Original language	English
Pages (from-to)	52-61
Journal	WIENER KLINISCHE WOCHENSCHRIFT
Volume	133
Issue number	1-2
DOIs	https://doi.org/10.1007/s00508-020-01761-3
Publication status	Published - 2021

Keywords

DEFINED ESSENTIAL THROMBOCYTHEMIA
RISK ESSENTIAL THROMBOCYTHEMIA
INTERNATIONAL WORKING GROUP
LONG-TERM SURVIVAL
BLOOD-CELL COUNTS
POLYCYTHEMIA-VERA
MYELOPROLIFERATIVE DISORDERS
CALRETICULIN MUTATIONS
MYELOFIBROSIS RESEARCH
ANTIPLATELET THERAPY

Access to Document

10.1007/s00508-020-01761-3

Cite this

@article{c5d49cb0117c4440b3a04f5517c76f25,

title = "Austrian recommendations for the management of essential thrombocythemia.",

keywords = "DEFINED ESSENTIAL THROMBOCYTHEMIA, RISK ESSENTIAL THROMBOCYTHEMIA, INTERNATIONAL WORKING GROUP, LONG-TERM SURVIVAL, BLOOD-CELL COUNTS, POLYCYTHEMIA-VERA, MYELOPROLIFERATIVE DISORDERS, CALRETICULIN MUTATIONS, MYELOFIBROSIS RESEARCH, ANTIPLATELET THERAPY",

author = "Veronika Buxhofer-Ausch and Sonja Heibl and Thamer Sliwa and Christine Beham-Schmid and Dominik Wolf and Klaus Geissler and Krauth, {Maria Theresa} and Peter Krippl and Andreas Petzer and Albert W{\"o}lfler and Thomas Melchardt and Heinz Gisslinger",

note = "Melchardt: Paracelsus Med Univ Hosp Salzburg, Lab Immunol *** Mol Canc Res, Med Dept Hematol *** Med Oncol Hemostaseol Rheumato, Salzburg, Austria; Lehr-KH: Ordensklinikum Linz Elisabethinen, Dept Internal Med Hematol Stem Cell Transplantat, Fadingerstr 1, A-4020 Linz, Austria; ",

year = "2021",

doi = "10.1007/s00508-020-01761-3",

language = "English",

volume = "133",

pages = "52--61",

journal = "WIENER KLINISCHE WOCHENSCHRIFT",

issn = "0043-5325",

publisher = "Springer Nature",

number = "1-2",

}

TY - JOUR

T1 - Austrian recommendations for the management of essential thrombocythemia.

AU - Buxhofer-Ausch, Veronika

AU - Heibl, Sonja

AU - Sliwa, Thamer

AU - Beham-Schmid, Christine

AU - Wolf, Dominik

AU - Geissler, Klaus

AU - Krauth, Maria Theresa

AU - Krippl, Peter

AU - Petzer, Andreas

AU - Wölfler, Albert

AU - Melchardt, Thomas

AU - Gisslinger, Heinz

N1 - Melchardt: Paracelsus Med Univ Hosp Salzburg, Lab Immunol *** Mol Canc Res, Med Dept Hematol *** Med Oncol Hemostaseol Rheumato, Salzburg, Austria; Lehr-KH: Ordensklinikum Linz Elisabethinen, Dept Internal Med Hematol Stem Cell Transplantat, Fadingerstr 1, A-4020 Linz, Austria;

PY - 2021

Y1 - 2021

KW - DEFINED ESSENTIAL THROMBOCYTHEMIA

KW - RISK ESSENTIAL THROMBOCYTHEMIA

KW - INTERNATIONAL WORKING GROUP

KW - LONG-TERM SURVIVAL

KW - BLOOD-CELL COUNTS

KW - POLYCYTHEMIA-VERA

KW - MYELOPROLIFERATIVE DISORDERS

KW - CALRETICULIN MUTATIONS

KW - MYELOFIBROSIS RESEARCH

KW - ANTIPLATELET THERAPY

U2 - 10.1007/s00508-020-01761-3

DO - 10.1007/s00508-020-01761-3

M3 - Original Article (Journal)

C2 - 33215234

SN - 0043-5325

VL - 133

SP - 52

EP - 61

JO - WIENER KLINISCHE WOCHENSCHRIFT

JF - WIENER KLINISCHE WOCHENSCHRIFT

IS - 1-2

ER -